Pharmacologist Kondrakhin said that Paxlovid is similar to the anti-HIV drug used in the Russian Federation .ru “that the composition of the drug Paxlovid, tested by the American pharmaceutical company Pfizer against COVID-19, is similar to the drug already used in Russia against the new coronavirus infection, which was originally created to fight the human immunodeficiency virus (HIV).
< p>Earlier, Vedomosti reported that Roszdravnadzor had given Pfizer permission to conduct clinical trials in Russia of Paxlovid, a protease inhibitor plus ritonavir, developed for the prevention and treatment of COVID-19. According to the developer, the second phase of clinical trials showed that Paxlovid helped reduce the risk of hospitalization or death from COVID-19 by 89 percent.
“It's called Find the Differences. We tried to treat at the beginning of the pandemic with ritonavir, there was the drug Kaletra, which was used to treat AIDS patients, it contains ritonavir and lopinavir, which is an inhibitor of the HIV-1 and HIV-2 proteases of the human immunodeficiency virus. That is, they left ritonavir and added a protease inhibitor, it turns out that this is a repetition of what we have already gone through, “the doctor noted. antiviral drugs – Favipiravir and Remdesivir, Kondrakhin said, however, he reacted positively to the possible launch of a new drug on the market: “It's good that there is a new drug, and it would be great if we could use it immediately at the first signs of the disease, but everything -See how it will behave. ” doctors refused to use it in the treatment of COVID-19.